Indeed, ipragliflozin improved endothelial dysfunction, restored the phosphorylation of Akt and eNOS, decreased the formation of ROS and the expression of pro-atherosclerotic factors in the abdominal aorta from streptozotocin-induced diabetic mice [43]. Here, AKT1 is linked to endothelial dysfunction.